Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer

European Journal of Cancer

Volumn 38, Issue 4, 2002, Pages 527-534

  Corsi, D C ^a   Ciaparrone, M ^a   Zannoni, G ^a   Mancini, M ^a   Cassano, A ^a   Specchia, M ^a   Pozzo, C ^a   Martini, M ^a   Barone, C ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Colorectal cancer; Immunohistochemistry; Metastases; Thymidylate synthase

Indexed keywords

FLUOROURACIL; FOLINIC ACID; MONOCLONAL ANTIBODY; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LEUCOVORIN; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; THYMIDYLATE SYNTHASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0036188129     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00402-6     Document Type: Article

References (36)

1. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients
2. Surgery for lung metastases from colorectal cancer: Analysis of prognostic factors
3. Adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver
4. Treatment of colorectal liver metastases
5. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver
6. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German cooperative on liver metastases (Arbeitsgruppe Lebermetastasen)
7. Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion fluorouracil and weekly leucovorin in disseminated colorectal cancer: Preliminary reports from an ongoing trial
8. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin
9. Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine
10. Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil based chemotherapy
11. Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma
12. Increased thymidylate synthase gene expression in liver metastases from colorectal carcinoma: Implications for chemotherapeutic options and survival
13. Thymidylate synthase protein expression in advanced colon cancer: Correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil
14. Chemotherapy for colorectal cancer
15. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and resistant human cancer cell lines
16. Thymidylate synthase and drug resistance
17. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluoruracil and interferon-gamma
18. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: A predictor for primary tumor response and overall survival
19. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer
20. A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance
21. Prognostic importance of thymidylate synthase expression in early breast cancer
22. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors
23. Immunohistochemical determination of thymidylate synthase in colorectal cancers - Methodological studies
24. Non-parametric estimation for incomplete observations
25. Statistical aspects of the analysis of data from retrospective studies of disease
26. Regression models and life-tables
27. Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy
28. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction
29. Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue
30. Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil
31. Regulation of thymidylate synthase activity in cultured mammalian cells
32. Cell cycle regulation of thymidylate synthase gene expression in cultured mouse fibroblasts
33. Increased thymidylate synthase protein levels are principally associated with proliferation but not cell cycle phase in asynchronous human cancer cells
34. Identification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells
35. Regulation of p53 expression by thymidylate synthase
36. Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed